These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 100739)

  • 1. Tolamolol, a beta adrenergic blocking agent: study of its efficacy in angina pectoris.
    Miscia VF; Holsinger JW; Pollicina F; Eliot RS
    Mil Med; 1978 Sep; 143(9):629-31. PubMed ID: 100739
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
    Nordenfelt I; Olsson L; Persson S
    Eur J Clin Pharmacol; 1974; 7(3):157-62. PubMed ID: 4152812
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Tolamolol in treatment of angina pectoris.
    Good C
    Br Med J; 1975 Jun; 2(5970):560. PubMed ID: 1173789
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Tolamolol in treatment of angina pectoris.
    Br Med J; 1975 Jul; 3(5976):156-7. PubMed ID: 1095140
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: tolamolol in treatment of angina pectoris.
    Oram S; Jackson G; Atkinson L
    Br Med J; 1975 Jun; 2(5972):686. PubMed ID: 1173562
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of two beta-adrenergic blocking drugs in angina pectoris.
    Stroescu V; Theodorini S; Creţescu R
    Rev Roum Med Intern; 1974; 11(3):307-11. PubMed ID: 4152108
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of nadolol in angina pectoris.
    Cruz J; Conceicao JM; Coelho EM
    Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
    [No Abstract]   [Full Text] [Related]  

  • 8. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas.
    Sipos Z; Hollósi Z; Iskum M
    Ther Hung; 1984; 32(2):74-8. PubMed ID: 6152819
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the adrenergic selective beta 1-blocker cordanum in the treatment of patients with angina pectoris complicating pulmonary pathology].
    Shastin NN; Zhuk AE; Zhivotov KA
    Sov Med; 1982; (10):11-6. PubMed ID: 6129708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation, by the bicycle ergometry test ECG, of the efficacy of a single dosage of nadolol, in patients with stable angina pectoris].
    Capuano V; De Vita S; Riccio MD; De Martino M; Mondillo G
    Minerva Cardioangiol; 1985 Nov; 33(11):739-44. PubMed ID: 2868431
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
    Thadani U; Davidson C; Singleton W; Taylor SH
    N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
    Luther RR; Glassman HN; Jordan DC; Klepper MJ
    J Int Med Res; 1986; 14(4):167-74. PubMed ID: 3093295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of metoprolol on systolic time in patients with stable angina pectoris].
    Mosti G; Tomei G; Veltri M; Giusti C
    Minerva Cardioangiol; 1979 Mar; 27(3):147-52. PubMed ID: 37463
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the anti-angina effectiveness of nadolol and propranolol].
    Cremonesi A; Pagliarani PL; Guelfi P; Mattace R; Costa G; Bernardi G; Zacà F
    Boll Soc Ital Cardiol; 1979; 24(7):741-5. PubMed ID: 45306
    [No Abstract]   [Full Text] [Related]  

  • 19. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
    Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of a prolonged-action beta-blocker (nadolol) in the therapy of stable angina. Ergometric study].
    Galati A; Coletta C; Carunchio A; Bordi L; Salustri A; Tornese C; Cigna G
    Minerva Cardioangiol; 1985 Dec; 33(12):845-50. PubMed ID: 2869449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.